Glaucoma Treatment Market
Glaucoma Treatment Market By Disease Type (Open Angle, Angle Closure, Others), Drug Class (Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) & Region - Forecast 2022 - 2032
Market Insights on Glaucoma Treatment covering sales outlook, demand forecast & up-to-date key trends
Glaucoma Treatment Market Outlook (2022-2032)
[331 Pages Report] The global glaucoma treatment market is expected to reach US$ 7.78 Bn in 2032, with a steady rate of 3.2% during the forecast period.
“Innovation of new technology with new pharmacological discoveries are expected to fuel the growth of the glaucoma treatment market.”
The rising frequency of glaucoma illnesses and the growing demand for sophisticated therapeutic methods are the primary reasons that led to the growth of the market. The glaucoma treatment market is expanding due to increased awareness of glaucoma due to government and pharmaceutical company promotions.
|
Attributes |
Details |
|
Glaucoma Treatment Market Size (2027) |
US$ 11.05 Bn |
|
Glaucoma Treatment Market Size CAGR (2022-2032) |
3.2% |
|
Glaucoma Treatment Market Size Attraction |
Growing infrastructure and demand for renewable energy to offer impetus. |
How COVID-19 affected the Glaucoma Treatment Market?
COVID-19 is a global public health disaster that has affected almost every company, and its long-term consequences are expected to have an influence on industry growth over the forecast period. Due to the adoption of preventive lockdown in various economies, the COVID-19 pandemic had a modest negative influence on glaucoma treatment market sales.
Due to a lack of healthcare infrastructure, COVID-19 patients will be given priority, and all resources will be mobilized. In addition, several ophthalmology departments were transformed into COVID-19 wards, limiting glaucoma patient follow-up.
Furthermore, lower demand for the glaucoma treatment market has occurred from fewer patient visits to clinical settings due to concern of infection among elderly persons. During the pandemic, however, the use of telemedicine platforms aided patients in receiving treatment on time, propelling the broader business forward.
Consumer demand has reduced as a result of the outbreak's negative impact on most people's general economic status since people are now more keen on cutting non-essential expenses from their varied budgets.
Let us know your requirement to get
100% FREE customization
What are the Driving Factors of the Glaucoma Treatment Market?
"Market is expanding as a result of technological advancements, increased awareness of glaucoma, and new drug developments."
Glaucoma incidences are rising, which is propelling the global Glaucoma Treatment Market forward. Glaucoma is a painless eye illness that does not cause any symptoms until it causes substantial vision loss; hence the number of glaucoma patients is growing by the day.
Furthermore, increasing awareness of glaucoma due to government and pharmaceutical company initiatives is propelling the glaucoma treatment market forward. As eye drops are the major control tool for glaucoma, and various pharmaceutical and biotechnological companies are investing in new product development for glaucoma, technical innovation in treatment is another driver for the market growth.
One of the primary factors driving the glaucoma treatment market outlook is continuous technological improvements in the ophthalmology industry. The industry's development potential will be fueled by the rising demand for improved surgical treatments.
Furthermore, medical imaging, selective laser trabeculoplasty (SLT), optical coherence tomography (OCT), visual fields, micro-invasive glaucoma surgery (MIGS), and progression analysis software will increase patient preference. Additionally, the market size will expand if laser therapies are combined with medications to treat glaucoma as first-line therapy.
What are the Emerging Trends in the Glaucoma Treatment Market?
Beta-blockers, alpha-adrenergic agonists, carbonic anhydrase inhibitors, and prostaglandin analogs are some drugs used to treat glaucoma, while a combination of medications is now commonly used. According to the World Health Organization, glaucoma affects more than 60 million people worldwide in 2019.
On the other hand, the Glaucoma Treatment Market views no discomfort and no symptoms other than visible vision loss to be a challenge. According to the Glaucoma Research Foundation, more than 120,000 people in the United States are blind due to glaucoma. As a result of the increased number of cases of glaucoma, the market is predicted to rise rapidly over the forecast period.
Comparative View of Adjacent Glaucoma Treatment Market
Glaucoma Treatment Market:
|
Attributes |
Glaucoma Treatment Market |
|
CAGR (2022 - 2032) |
3.2% |
|
Market Value (2026) |
US$ 11 Bn |
|
Growth Factor |
Innovation in new technologies to offer impetus to the market. |
|
Opportunity |
Investments in prostaglandin analogs to create opportunities. |
|
Key Trends |
Ease of use of eye drops to remain a dominant market trend. |
Glaucoma Therapeutics Market:
|
Attributes |
Glaucoma Therapeutics Market |
|
CAGR (2022 - 2032) |
6.7% |
|
Market Value (2026) |
US$ 10 Bn |
|
Growth Factor |
Rising research towards the development of prostaglandin analogs to boost adoption. |
|
Opportunity |
Robust healthcare infrastructure in emerging countries to sustain demand. |
|
Key Trends |
Development of effective therapeutics with ease of use to drive the market growth. |
Glaucoma Surgery Devices Market:
|
Attributes |
Glaucoma Surgery Devices Market |
|
CAGR (2022 - 2032) |
25% |
|
Market Value (2026) |
US$ 60 Bn |
|
Growth Factor |
Rising awareness about the condition to offer growth prospects. |
|
Opportunity |
Demand for minimally invasive surgeries to offer opportunities. |
|
Key Trends |
Intense focus on advanced technology for product development to remain a key trend. |
Glaucoma is the second leading cause of blindness worldwide. This is usually caused by increased intraocular tension. Lowering intraocular tension is the main glaucoma treatment goal. This is accomplished by either decreasing aqueous humor secretion or boosting drainage.
Open-angle (wide angle) glaucoma, chronic glaucoma, angle-closure (narrow-angle) glaucoma, and acute congestive glaucoma are all types of glaucoma. Although glaucoma medications help alleviate symptoms, there is no cure for the disease.
Glaucoma is a progressive optic neuropathy illness characterized by degeneration of the retinal nerve fiber layers and retinal ganglion cells, resulting in alterations in the optical nerve head. High intraocular pressure (IOP) is a key risk factor, as it can damage the optic nerve, which can lead to irreversible visual field abnormalities, visual impairment, and blindness.
Glaucoma can cause permanent blindness around the globe. Medications for the eyes include eye drops to improve fluid outflow or decrease fluid production. In the event of angle-closure glaucoma, a laser is occasionally used to enhance drainage (in the angle) or make a hole in the iris or colored area of the eye.
Filtering surgery and tube-shunt surgery are two eye surgical methods that can construct an alternate fluid drainage system in the eye. Reduced eye pressure is used to treat glaucoma. Depending on your situation, prescription eye drops, oral medicines, laser treatment, surgery, or a combination of these may be offered.
Glaucoma is commonly treated with prescription eye drops. These can help lower eye pressure by altering how fluid drains from your eye or reducing the amount produced.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhich Segment has the Highest Market Potential?
In 2021, the open-angle glaucoma segment was worth more than USD 4.5 billion. The high prevalence of open-angle glaucoma around the world is responsible for the segment's rise. Furthermore, the increasing use of hypotensive medications to lower intraocular pressure leads to segmental enlargement.
Prostaglandin analogs are widely used to lower intraocular pressure. They have various advantages, including once-daily dosage efficacy and a faster recovery rate in glaucoma treatment, which will drive market demand. Owing to the rising accessibility and affordability of ophthalmic drugs around the world, the prostaglandin analogs sector held a market share of more than 30% in 2021.
Furthermore, the rising demand for prostaglandin medicines in combination therapy is expected to significantly boost the segment's growth. Furthermore, improving patient awareness of early glaucoma therapy and an increase in the number of patients diagnosed with early glaucoma disease will raise total market statistics.
What Leads to a High Demand for the Hospital Pharmacy Segment?
In 2021, the hospital pharmacy segment was worth more than USD 3 billion. Throughout the analysis, the segment is expected to grow significantly. The significant growth is due to the widespread availability of products in various settings for various forms of glaucoma therapy.
Patient's preference for hospital pharmacies for prescribed medications also contributes to income growth. Furthermore, reimbursement rules and insurance coverage for drug purchases made in hospital settings are expected to improve market predictions.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
What is the Geographical Outlook for the Glaucoma Treatment Market?
Over the forecast timeframe, the North American glaucoma treatment market is expected to increase at a CAGR of 3.4%. The rising prevalence of various types of glaucoma in the region would boost the demand for glaucoma therapies.
The market will grow as more people become aware of the importance of eye care and the associated diagnoses and treatments. Furthermore, the region's significant presence of important market companies involved in new drug research and product approvals would boost regional industry growth.
Due to the increased glaucoma incidence and improved healthcare infrastructure, the United States is likely to be the largest glaucoma treatment market. According to the BrightFocus Foundation, more than 3 million Americans are affected by glaucoma, with open-angle glaucoma being the most frequent type.
Furthermore, glaucoma costs the US economy approximately USD 2.86 billion in direct costs and productivity losses each year. In addition, many organizations in the United States are raising awareness of glaucoma, which is projected to boost the market's overall growth.
How does the Competition Intensify in the Glaucoma Treatment Market?
Merck & Co., Inc., AERIE Pharmaceuticals, Inc., Cipla Inc, AbbVie, Akorn operating company LLC, Bausch & Lomb Incorporated, Inotek Pharmaceuticals, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Santen Pharmaceutical Co., Ltd. are some of the major players in the glaucoma treatment market.
To acquire a competitive advantage over competitors in the glaucoma treatment market, these industry players use different growth methods, such as collaboration, partnership, acquisition & merger, and product introduction.
- Teva Pharmaceuticals announced the first generic version of AZOPT (brinzolamide ophthalmic suspension) 1 percent in March 2021 in the United States to treat open-angle glaucoma and ocular hypertension. The company's product portfolio has been strengthened as a result of this.
- Aerie Pharmaceuticals and Santen Pharmaceuticals partnered in December 2021 to develop and market Rhopressa/Rhokiinsa and Rocklatan/Roclanda for glaucoma therapy in Europe, India, China, Oceania, and parts of Latin America. Both companies' market positions in these regions will be strengthened due to this.
Key segments
By Disease Type:
- Open Angle Glaucoma
- Angle Closure Glaucoma
- Other
By Drug Class:
- Prostaglandin Analog
- Beta Blockers
- Adrenergic Agonist
- Carbonic Anhydrase Inhibitors
- Others
By Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Frequently Asked Questions
The glaucoma treatment market is estimated to record a 3.2% CAGR during the forecast period.
The projected value of the glaucoma treatment market is expected to be US$ 7.78 Bn by 2032.
The global glaucoma treatment market was valued at US$ 5.5 Bn in 2021.
Hospital pharmacy segment accounts for the largest revenue share.
North America is growing at the highest CAGR during the forecast period.
1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Fact.MR Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Glaucoma Treatment Demand
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. Glaucoma Treatment Market, by Key Countries
4.2. Glaucoma Treatment Market Opportunity Assessment (US$ Mn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in Optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Glaucoma Treatment Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Glaucoma Treatment Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Glaucoma Treatment Market Demand Analysis 2015-2021 and Forecast, 2022-2032
6.1. Historical Market Analysis, 2015-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Glaucoma Treatment Market Value Analysis 2015-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Glaucoma Treatment Market Analysis 2015-2021 and Forecast 2022-2032, By Disease Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Disease Type, 2015-2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease Type, 2022-2032
8.3.1. Open Angle Glaucoma
8.3.2. Angle Closure Glaucoma
8.3.3. Others
8.4. Market Attractiveness Analysis By Disease Type
9. Global Glaucoma Treatment Market Analysis 2015-2021 and Forecast 2022-2032, By Drug Class
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Drug Class, 2015-2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Class, 2022-2032
9.3.1. Prostaglandin Analogs
9.3.2. Beta Blockers
9.3.3. Adrenergic Agonists
9.3.4. Carbonic Anhydrase Inhibitors
9.3.5. Others
9.4. Market Attractiveness Analysis By Drug Class
10. Global Glaucoma Treatment Market Analysis 2015-2021 and Forecast 2022-2032, By Distribution Channel
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Disease Type, 2015-2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022-2032
10.3.1. Hospital Pharmacy
10.3.2. Retail Pharmacy
10.3.3. Online Pharmacy
10.4. Market Attractiveness Analysis By Distribution Channel
11. Global Glaucoma Treatment Market Analysis 2015-2021 and Forecast 2022-2032, By Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021
11.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. Asia Pacific
11.3.5. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Glaucoma Treatment Market Analysis 2015-2021 and Forecast 2022-2032
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
12.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
12.4.1. By Country
12.4.1.1. U.S.
12.4.1.2. Canada
12.4.1.3. Rest of North America
12.4.2. By Disease Type
12.4.3. By Distribution Channel
12.4.4. By Drug Class
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Disease Type
12.5.3. By Distribution Channel
12.5.4. By Drug Class
13. Latin America Glaucoma Treatment Market Analysis 2015-2021 and Forecast 2022-2032
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
13.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
13.4.1. By Country
13.4.1.1. Brazil
13.4.1.2. Mexico
13.4.1.3. Rest of Latin America
13.4.2. By Disease Type
13.4.3. By Distribution Channel
13.4.4. By Drug Class
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Disease Type
13.5.3. By Distribution Channel
13.5.4. By Drug Class
14. Europe Glaucoma Treatment Market Analysis 2015-2021 and Forecast 2022-2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
14.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
14.4.1. By Country
14.4.1.1. Germany
14.4.1.2. France
14.4.1.3. U.K.
14.4.1.4. Italy
14.4.1.5. Benelux
14.4.1.6. Nordic Countries
14.4.1.7. Rest of Europe
14.4.2. By Disease Type
14.4.3. By Distribution Channel
14.4.4. By Drug Class
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Disease Type
14.5.3. By Distribution Channel
14.5.4. By Drug Class
15. Asia Pacific Glaucoma Treatment Market Analysis 2015-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
15.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
15.4.1. By Country
15.4.1.1. China
15.4.1.2. Japan
15.4.1.3. South Korea
15.4.1.4. Rest of Asia Pacific
15.4.2. By Disease Type
15.4.3. By Distribution Channel
15.4.4. By Drug Class
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Disease Type
15.5.3. By Distribution Channel
15.5.4. By Drug Class
16. Middle East and Africa Glaucoma Treatment Market Analysis 2015-2021 and Forecast 2022-2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
16.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
16.4.1. By Country
16.4.1.1. GCC Countries
16.4.1.2. South Africa
16.4.1.3. Turkey
16.4.1.4. Rest of Middle East and Africa
16.4.2. By Disease Type
16.4.3. By Distribution Channel
16.4.4. By Drug Class
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Disease Type
16.5.3. By Distribution Channel
16.5.4. By Drug Class
17. Key Countries Glaucoma Treatment Market Analysis 2015-2021 and Forecast 2022-2032
17.1. Introduction
17.1.1. Market Value Proportion Analysis, By Key Countries
17.1.2. Global Vs. Country Growth Comparison
17.2. US Glaucoma Treatment Market Analysis
17.2.1. Value Proportion Analysis by Market Taxonomy
17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.2.2.1. By Disease Type
17.2.2.2. By Distribution Channel
17.2.2.3. By Drug Class
17.3. Canada Glaucoma Treatment Market Analysis
17.3.1. Value Proportion Analysis by Market Taxonomy
17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.3.2.1. By Disease Type
17.3.2.2. By Distribution Channel
17.3.2.3. By Drug Class
17.4. Mexico Glaucoma Treatment Market Analysis
17.4.1. Value Proportion Analysis by Market Taxonomy
17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.4.2.1. By Disease Type
17.4.2.2. By Distribution Channel
17.4.2.3. By Drug Class
17.5. Brazil Glaucoma Treatment Market Analysis
17.5.1. Value Proportion Analysis by Market Taxonomy
17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.5.2.1. By Disease Type
17.5.2.2. By Distribution Channel
17.5.2.3. By Drug Class
17.6. Germany Glaucoma Treatment Market Analysis
17.6.1. Value Proportion Analysis by Market Taxonomy
17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.6.2.1. By Disease Type
17.6.2.2. By Distribution Channel
17.6.2.3. By Drug Class
17.7. France Glaucoma Treatment Market Analysis
17.7.1. Value Proportion Analysis by Market Taxonomy
17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.7.2.1. By Disease Type
17.7.2.2. By Distribution Channel
17.7.2.3. By Drug Class
17.8. Italy Glaucoma Treatment Market Analysis
17.8.1. Value Proportion Analysis by Market Taxonomy
17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.8.2.1. By Disease Type
17.8.2.2. By Distribution Channel
17.8.2.3. By Drug Class
17.9. BENELUX Glaucoma Treatment Market Analysis
17.9.1. Value Proportion Analysis by Market Taxonomy
17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.9.2.1. By Disease Type
17.9.2.2. By Distribution Channel
17.9.2.3. By Drug Class
17.10. UK Glaucoma Treatment Market Analysis
17.10.1. Value Proportion Analysis by Market Taxonomy
17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.10.2.1. By Disease Type
17.10.2.2. By Distribution Channel
17.10.2.3. By Drug Class
17.11. Nordic Countries Glaucoma Treatment Market Analysis
17.11.1. Value Proportion Analysis by Market Taxonomy
17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.11.2.1. By Disease Type
17.11.2.2. By Distribution Channel
17.11.2.3. By Drug Class
17.12. China Glaucoma Treatment Market Analysis
17.12.1. Value Proportion Analysis by Market Taxonomy
17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.12.2.1. By Disease Type
17.12.2.2. By Distribution Channel
17.12.2.3. By Drug Class
17.13. Japan Glaucoma Treatment Market Analysis
17.13.1. Value Proportion Analysis by Market Taxonomy
17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.13.2.1. By Disease Type
17.13.2.2. By Distribution Channel
17.13.2.3. By Drug Class
17.14. South Korea Glaucoma Treatment Market Analysis
17.14.1. Value Proportion Analysis by Market Taxonomy
17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.14.2.1. By Disease Type
17.14.2.2. By Distribution Channel
17.14.2.3. By Drug Class
17.15. GCC Countries Glaucoma Treatment Market Analysis
17.15.1. Value Proportion Analysis by Market Taxonomy
17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.15.2.1. By Disease Type
17.15.2.2. By Distribution Channel
17.15.2.3. By Drug Class
17.16. South Africa Glaucoma Treatment Market Analysis
17.16.1. Value Proportion Analysis by Market Taxonomy
17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.16.2.1. By Disease Type
17.16.2.2. By Distribution Channel
17.16.2.3. By Drug Class
17.17. Turkey Glaucoma Treatment Market Analysis
17.17.1. Value Proportion Analysis by Market Taxonomy
17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.17.2.1. By Disease Type
17.17.2.2. By Distribution Channel
17.17.2.3. By Drug Class
17.17.3. Competition Landscape and Player Concentration in the Country
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies
18.2. Market Concentration
18.3. Market Share Analysis of Top Players
18.4. Market Presence Analysis
18.4.1. By Regional footprint of Players
18.4.2. Product footprint by Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
19.3.1. AERIE Pharmaceuticals, Inc.
19.3.1.1. Overview
19.3.1.2. Product Portfolio
19.3.1.3. Sales Footprint
19.3.1.4. Strategy Overview
19.3.2. Cipla Inc.
19.3.2.1. Overview
19.3.2.2. Product Portfolio
19.3.2.3. Sales Footprint
19.3.2.4. Strategy Overview
19.3.3. Akorn Operating Company LLC
19.3.3.1. Overview
19.3.3.2. Product Portfolio
19.3.3.3. Sales Footprint
19.3.3.4. Strategy Overview
19.3.4. AbbVie
19.3.4.1. Overview
19.3.4.2. Product Portfolio
19.3.4.3. Sales Footprint
19.3.4.4. Strategy Overview
19.3.5. Bausch & Lomb Incorporated
19.3.5.1. Overview
19.3.5.2. Product Portfolio
19.3.5.3. Sales Footprint
19.3.5.4. Strategy Overview
19.3.6. Inotek Pharmaceuticals
19.3.6.1. Overview
19.3.6.2. Product Portfolio
19.3.6.3. Sales Footprint
19.3.6.4. Strategy Overview
19.3.7. Merck & Co., Inc.
19.3.7.1. Overview
19.3.7.2. Product Portfolio
19.3.7.3. Sales Footprint
19.3.7.4. Strategy Overview
19.3.8. Novartis AG
19.3.8.1. Overview
19.3.8.2. Product Portfolio
19.3.8.3. Sales Footprint
19.3.8.4. Strategy Overview
19.3.9. Pfizer Inc.
19.3.9.1. Overview
19.3.9.2. Product Portfolio
19.3.9.3. Sales Footprint
19.3.9.4. Strategy Overview
19.3.10. Santen Pharmaceutical Co., Ltd.
19.3.10.1. Overview
19.3.10.2. Product Portfolio
19.3.10.3. Sales Footprint
19.3.10.4. Strategy Overview
20. Assumptions and Acronyms Used
21. Research Methodology
Let us know your requirement to get
100% FREE customization
Table 1: Global Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2015 – 2021
Table 2: Global Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2022 – 2032
Table 3: Global Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2015 – 2021
Table 4: Global Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2022 – 2032
Table 5: Global Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2015 – 2021
Table 6: Global Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2022 – 2032
Table 7: Global Glaucoma Treatment Market, By Region, 2015 – 2021
Table 8: Global Glaucoma Treatment Market, By Region, 2022 – 2032
Table 9: North America Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2015 – 2021
Table 10: North America Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2022 – 2032
Table 11: North America Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2015 – 2021
Table 12: North America Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2022 – 2032
Table 13: North America Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2015 – 2021
Table 14: North America Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2022 – 2032
Table 15: North America Glaucoma Treatment Market, By Country, 2015 – 2021
Table 16: North America Glaucoma Treatment Market, By Country, 2022 – 2032
Table 17: Latin America Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2015 – 2021
Table 18: Latin America Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2022 – 2032
Table 19: Latin America Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2015 – 2021
Table 20: Latin America Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2022 – 2032
Table 21: Latin America Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2015 – 2021
Table 22: Latin America Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2022 – 2032
Table 23: Latin America Glaucoma Treatment Market, By Country, 2015 – 2021
Table 24: Latin America Glaucoma Treatment Market, By Country, 2022 – 2032
Table 25: Europe Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2015 – 2021
Table 26: Europe Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2022 – 2032
Table 27: Europe Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2015 – 2021
Table 28: Europe Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2022 – 2032
Table 29: Europe Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2015 – 2021
Table 30: Europe Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2022 – 2032
Table 31: Europe Glaucoma Treatment Market, By Country, 2015 – 2021
Table 32: Europe Glaucoma Treatment Market, By Country, 2022 – 2032
Table 33: Asia Pacific Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2015 – 2021
Table 34: Asia Pacific Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2022 – 2032
Table 35: Asia Pacific Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2015 – 2021
Table 36: Asia Pacific Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2022 – 2032
Table 37: Asia Pacific Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2015 – 2021
Table 38: Asia Pacific Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2022 – 2032
Table 39: Asia Pacific Glaucoma Treatment Market, By Country, 2015 – 2021
Table 40: Asia Pacific Glaucoma Treatment Market, By Country, 2022 – 2032
Table 41: MEA Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2015 – 2021
Table 42: MEA Glaucoma Treatment Market Value (US$ Mn), By Disease Type, 2022 – 2032
Table 43: MEA Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2015 – 2021
Table 44: MEA Glaucoma Treatment Market Value (US$ Mn), By Distribution Channel, 2022 – 2032
Table 45: MEA Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2015 – 2021
Table 46: MEA Glaucoma Treatment Market Value (US$ Mn), By Drug Class, 2022 – 2032
Table 47: MEA Glaucoma Treatment Market, By Country, 2015 – 2021
Table 48: MEA Glaucoma Treatment Market, By Country, 2022 – 2032
Table 49: Global Glaucoma Treatment Market Incremental $ Opportunity, By Disease Type, 2015 - 2021
Table 50: Global Glaucoma Treatment Market Incremental $ Opportunity, By Distribution Channel, 2022 – 2032
Table 51: Global Glaucoma Treatment Market Incremental $ Opportunity, By Drug Class, 2015 - 2021
Table 52: Global Glaucoma Treatment Market Incremental $ Opportunity, By Region, 2022 – 2032
Table 53: North America Glaucoma Treatment Market Incremental $ Opportunity, By Disease Type, 2015 - 2021
Table 54: North America Glaucoma Treatment Market Incremental $ Opportunity, By Distribution Channel, 2022 – 2032
Table 55: North America Glaucoma Treatment Market Incremental $ Opportunity, By Drug Class, 2015 – 2021
Table 56: North America Glaucoma Treatment Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 57: Latin America Glaucoma Treatment Market Incremental $ Opportunity, By Disease Type, 2015 - 2021
Table 58: Latin America Glaucoma Treatment Market Incremental $ Opportunity, By Distribution Channel, 2022 – 2032
Table 59: Latin America Glaucoma Treatment Market Incremental $ Opportunity, By Drug Class, 2015 - 2021
Table 60: Latin America Glaucoma Treatment Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 61: Europe Glaucoma Treatment Market Incremental $ Opportunity, By Disease Type, 2015 - 2021
Table 62: Europe Glaucoma Treatment Market Incremental $ Opportunity, By Distribution Channel, 2022 – 2032
Table 63: Europe Glaucoma Treatment Market Incremental $ Opportunity, By Drug Class, 2015 - 2021
Table 64: Europe Glaucoma Treatment Market Incremental $ Opportunity, By Country, 2022 - 2032
Table 65: Asia Pacific Glaucoma Treatment Market Incremental $ Opportunity, By Disease Type, 2015 - 2021
Table 66: Asia Pacific Glaucoma Treatment Market Incremental $ Opportunity, By Distribution Channel, 2022 – 2032
Table 67: Asia Pacific Glaucoma Treatment Market Incremental $ Opportunity, By Distribution Channel, 2015 - 2021
Table 68: Asia Pacific Glaucoma Treatment Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 69: MEA Glaucoma Treatment Market Incremental $ Opportunity, By Disease Type, 2015 - 2021
Table 70: MEA Glaucoma Treatment Market Incremental $ Opportunity, By Disease Type, 2022 – 2032
Table 71: MEA Glaucoma Treatment Market Incremental $ Opportunity, By Drug Class, 2015 - 2021
Table 72: MEA Glaucoma Treatment Market Incremental $ Opportunity, By Country, 2022 - 2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystFigure 1: Global Glaucoma Treatment Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 2: Global Glaucoma Treatment Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 3: Global Glaucoma Treatment Market Share, By Disease Type, 2022 & 2032
Figure 4: Global Glaucoma Treatment Market Y-o-Y Growth Projections, By Disease Type – 2022-2032
Figure 5: Global Glaucoma Treatment Market Attractiveness Index, By Disease Type – 2022-2032
Figure 6: Global Glaucoma Treatment Market Share, By Distribution Channel, 2022 & 2032
Figure 7: Global Glaucoma Treatment Market Y-o-Y Growth Projections, By Distribution Channel – 2022-2032
Figure 8: Global Glaucoma Treatment Market Attractiveness Index, By Distribution Channel – 2022-2032
Figure 9: Global Glaucoma Treatment Market Share, By Drug Class, 2022 & 2032
Figure 10: Global Glaucoma Treatment Market Y-o-Y Growth Projections, By Drug Class – 2022-2032
Figure 11: Global Glaucoma Treatment Market Attractiveness Index, By Drug Class – 2022-2032
Figure 12: Global Glaucoma Treatment Market Share, By Region, 2022 & 2032
Figure 13: Global Glaucoma Treatment Market Y-o-Y Growth Projections, By Region – 2022-2032
Figure 14: Global Glaucoma Treatment Market Attractiveness Index, By Region – 2022-2032
Figure 15: North America Glaucoma Treatment Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 16: North America Glaucoma Treatment Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 17: North America Glaucoma Treatment Market Share, By Disease Type, 2022 & 2032
Figure 18: North America Glaucoma Treatment Market Y-o-Y Growth Projections, By Disease Type – 2022-2032
Figure 19: North America Glaucoma Treatment Market Attractiveness Index, By Disease Type – 2022-2032
Figure 20: North America Glaucoma Treatment Market Share, By Distribution Channel, 2022 & 2032
Figure 21: North America Glaucoma Treatment Market Y-o-Y Growth Projections, By Distribution Channel – 2022-2032
Figure 22: North America Glaucoma Treatment Market Attractiveness Index, By Distribution Channel – 2022-2032
Figure 23: North America Glaucoma Treatment Market Share, By Drug Class, 2022 & 2032
Figure 24: North America Glaucoma Treatment Market Y-o-Y Growth Projections, By Drug Class – 2022-2032
Figure 25: North America Glaucoma Treatment Market Attractiveness Index, By Drug Class – 2022-2032
Figure 26: North America Glaucoma Treatment Market Share, By Country, 2022 & 2032
Figure 27: North America Glaucoma Treatment Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 28: North America Glaucoma Treatment Market Attractiveness Index, By Country – 2022-2032
Figure 29: Latin America Glaucoma Treatment Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 30: Latin America Glaucoma Treatment Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 31: Latin America Glaucoma Treatment Market Share, By Disease Type, 2022 & 2032
Figure 32: Latin America Glaucoma Treatment Market Y-o-Y Growth Projections, By Disease Type – 2022-2032
Figure 33: Latin America Glaucoma Treatment Market Attractiveness Index, By Disease Type – 2022-2032
Figure 34: Latin America Glaucoma Treatment Market Share, By Distribution Channel, 2022 & 2032
Figure 35: Latin America Glaucoma Treatment Market Y-o-Y Growth Projections, By Distribution Channel – 2022-2032
Figure 36: Latin America Glaucoma Treatment Market Attractiveness Index, By Distribution Channel – 2022-2032
Figure 37: Latin America Glaucoma Treatment Market Share, By Drug Class, 2022 & 2032
Figure 38: Latin America Glaucoma Treatment Market Y-o-Y Growth Projections, By Drug Class – 2022-2032
Figure 39: Latin America Glaucoma Treatment Market Attractiveness Index, By Drug Class – 2022-2032
Figure 40: Latin America Glaucoma Treatment Market Share, By Country, 2022 & 2032
Figure 41: Latin America Glaucoma Treatment Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 42: Latin America Glaucoma Treatment Market Attractiveness Index, By Country – 2022-2032
Figure 43: Europe Glaucoma Treatment Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 44: Europe Glaucoma Treatment Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 45: Europe Glaucoma Treatment Market Share, By Disease Type, 2022 & 2032
Figure 46: Europe Glaucoma Treatment Market Y-o-Y Growth Projections, By Disease Type – 2022-2032
Figure 47: Europe Glaucoma Treatment Market Attractiveness Index, By Disease Type – 2022-2032
Figure 48: Europe Glaucoma Treatment Market Share, By Distribution Channel, 2022 & 2032
Figure 49: Europe Glaucoma Treatment Market Y-o-Y Growth Projections, By Distribution Channel – 2022-2032
Figure 50: Europe Glaucoma Treatment Market Attractiveness Index, By Distribution Channel – 2022-2032
Figure 51: Europe Glaucoma Treatment Market Share, By Drug Class, 2022 & 2032
Figure 52: Europe Glaucoma Treatment Market Y-o-Y Growth Projections, By Drug Class – 2022-2032
Figure 53: Europe Glaucoma Treatment Market Attractiveness Index, By Drug Class – 2022-2032
Figure 54: Europe Glaucoma Treatment Market Share, By Country, 2022 & 2032
Figure 55: Europe Glaucoma Treatment Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 56: Europe Glaucoma Treatment Market Attractiveness Index, By Country – 2022-2032
Figure 57: MEA Glaucoma Treatment Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 58: MEA Glaucoma Treatment Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 59: MEA Glaucoma Treatment Market Share, By Disease Type, 2022 & 2032
Figure 60: MEA Glaucoma Treatment Market Y-o-Y Growth Projections, By Disease Type – 2022-2032
Figure 61: MEA Glaucoma Treatment Market Attractiveness Index, By Disease Type – 2022-2032
Figure 62: MEA Glaucoma Treatment Market Share, By Distribution Channel, 2022 & 2032
Figure 63: MEA Glaucoma Treatment Market Y-o-Y Growth Projections, By Distribution Channel – 2022-2032
Figure 64: MEA Glaucoma Treatment Market Attractiveness Index, By Distribution Channel – 2022-2032
Figure 65: MEA Glaucoma Treatment Market Share, By Drug Class, 2022 & 2032
Figure 66: MEA Glaucoma Treatment Market Y-o-Y Growth Projections, By Drug Class – 2022-2032
Figure 67: MEA Glaucoma Treatment Market Attractiveness Index, By Drug Class – 2022-2032
Figure 68: MEA Glaucoma Treatment Market Share, By Country, 2022 & 2032
Figure 69: MEA Glaucoma Treatment Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 70: MEA Glaucoma Treatment Market Attractiveness Index, By Country – 2022-2032
Figure 71: Asia Pacific Glaucoma Treatment Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 72: Asia Pacific Glaucoma Treatment Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 73: Asia Pacific Glaucoma Treatment Market Share, By Disease Type, 2022 & 2032
Figure 74: Asia Pacific Glaucoma Treatment Market Y-o-Y Growth Projections, By Disease Type – 2022-2032
Figure 75: Asia Pacific Glaucoma Treatment Market Attractiveness Index, By Disease Type – 2022-2032
Figure 76: Asia Pacific Glaucoma Treatment Market Share, By Distribution Channel, 2022 & 2032
Figure 77: Asia Pacific Glaucoma Treatment Market Y-o-Y Growth Projections, By Distribution Channel – 2022-2032
Figure 78: Asia Pacific Glaucoma Treatment Market Attractiveness Index, By Distribution Channel – 2022-2032
Figure 79: Asia Pacific Glaucoma Treatment Market Share, By Drug Class, 2022 & 2032
Figure 80: Asia Pacific Glaucoma Treatment Market Y-o-Y Growth Projections, By Drug Class – 2022-2032
Figure 81: Asia Pacific Glaucoma Treatment Market Attractiveness Index, By Drug Class – 2022-2032
Figure 82: Asia Pacific Glaucoma Treatment Market Share, By Country, 2022 & 2032
Figure 83: Asia Pacific Glaucoma Treatment Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 84: Asia Pacific Glaucoma Treatment Market Attractiveness Index, By Country – 2022-2032
Figure 85: US Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 86: US Glaucoma Treatment Market Share, By Disease Type, 2021
Figure 87: US Glaucoma Treatment Market Share, By Distribution Channel, 2021
Figure 88: US Glaucoma Treatment Market Share, By Drug Class, 2021
Figure 89: Canada Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 90: Canada Glaucoma Treatment Market Share, By Disease Type, 2021
Figure 91: Canada Glaucoma Treatment Market Share, By Distribution Channel, 2021
Figure 92: Canada Glaucoma Treatment Market Share, By Drug Class, 2021
Figure 93: Brazil Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 94: Brazil Glaucoma Treatment Market Share, By Disease Type, 2021
Figure 95: Brazil Glaucoma Treatment Market Share, By Distribution Channel, 2021
Figure 96: Brazil Glaucoma Treatment Market Share, By Drug Class, 2021
Figure 97: Mexico Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 98: Mexico Glaucoma Treatment Market Share, By Disease Type, 2021
Figure 99: Mexico Glaucoma Treatment Market Share, By Distribution Channel, 2021
Figure 100: Mexico Glaucoma Treatment Market Share, By Drug Class, 2021
Figure 101: Germany Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 102: Germany Glaucoma Treatment Market Share, By Disease Type, 2021
Figure 103: Germany Glaucoma Treatment Market Share, By Distribution Channel, 2021
Figure 104: Germany Glaucoma Treatment Market Share, By Drug Class, 2021
Figure 105: U.K. Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 106: U.K. Glaucoma Treatment Market Share, By Disease Type, 2021
Figure 107: U.K. Glaucoma Treatment Market Share, By Distribution Channel, 2021
Figure 108: U.K. Glaucoma Treatment Market Share, By Drug Class, 2021
Figure 109: France Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 110: France Glaucoma Treatment Market Share, By Disease Type, 2021
Figure 111: France Glaucoma Treatment Market Share, By Distribution Channel, 2021
Figure 112: France Glaucoma Treatment Market Share, By Drug Class, 2021
Figure 113: Italy Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 114: Italy Glaucoma Treatment Market Share, By Disease Type, 2021
Figure 115: Italy Glaucoma Treatment Market Share, By Distribution Channel, 2021
Figure 116: Italy Glaucoma Treatment Market Share, By Drug Class, 2021
Figure 117: BENELUX Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 118: BENELUX Glaucoma Treatment Market Share, By Disease Type, 2021
Figure 119: BENELUX Glaucoma Treatment Market Share, By Distribution Channel, 2021
Figure 120: BENELUX Glaucoma Treatment Market Share, By Drug Class, 2021
Figure 121: Nordic Countries Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 122: Nordic Countries Glaucoma Treatment Market Share, By Disease Type, 2021
Figure 123: Nordic Countries Glaucoma Treatment Market Share, By Distribution Channel, 2021
Figure 124: Nordic Countries Glaucoma Treatment Market Share, By Drug Class, 2021
Figure 125: China Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 126: China Glaucoma Treatment Market Share, By Disease Type, 2021
Figure 127: China Glaucoma Treatment Market Share, By Distribution Channel, 2021
Figure 128: China Glaucoma Treatment Market Share, By Drug Class, 2021
Figure 129: Japan Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 130: Japan Glaucoma Treatment Market Share, By Disease Type, 2021
Figure 131: Japan Glaucoma Treatment Market Share, By Distribution Channel, 2021
Figure 132: Japan Glaucoma Treatment Market Share, By Drug Class, 2021
Figure 133: South Korea Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 134: South Korea Glaucoma Treatment Market Share, By Disease Type, 2021
Figure 135: South Korea Glaucoma Treatment Market Share, By Distribution Channel, 2021
Figure 136: South Korea Glaucoma Treatment Market Share, By Drug Class, 2021
Figure 137: GCC Countries Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 138: GCC Countries Glaucoma Treatment Market Share, By Disease Type, 2021
Figure 139: GCC Countries Glaucoma Treatment Market Share, By Distribution Channel, 2021
Figure 140: GCC Countries Glaucoma Treatment Market Share, By Drug Class, 2021
Figure 141: South Africa Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 142: South Africa Glaucoma Treatment Market Share, By Disease Type, 2021
Figure 143: South Africa Glaucoma Treatment Market Share, By Distribution Channel, 2021
Figure 144: South Africa Glaucoma Treatment Market Share, By Drug Class, 2021
Figure 145: Turkey Glaucoma Treatment Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 146: Turkey Glaucoma Treatment Market Share, By Disease Type, 2021
Figure 147: Turkey Glaucoma Treatment Market Share, By Distribution Channel, 2021
Figure 148: Turkey Glaucoma Treatment Market Share, By Drug Class, 2021
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
